Similarly, treatment with an HMGB1 monoclonal neutralizing antibody can alleviate the phenotype of MRL/lpr and BXSB Lupus mice, but it has also been shown to be ineffective in MRL/lpr mice (20). The gene discussed is HMGB1; the disease is systemic lupus erythematosus.